Tedco awards $600K to tech firms - Houston Business Journal:

sucujovide.wordpress.com
The money was granted in collaborationj withthe U.S. Army Medical Researcyh and Materiel Command and the throughthe Ft. Detrick Technology Transfed Initiative. The purpose of the technology transfe r program is to raise awareness of new and developintg technologies and funding them to transitioj as viable projectsfor follow-on funding in the market place. Each company that received funding was awardedapproximately $50,0090 between March 2008 and May 2009, making up the initiative’w second round of financial awardws since its $750,000 program extension. The funds for the program’ s second phase were secured by Sen. Barbarwa Mikulski, D-Md., and Rep. Roscose G. Bartlett, R-Md.
“The [Ft. Detric k Technology Transfer Initiative] program is enabling area businesses to harness the technologiesa being developed at Fort Detrick and apply them to the commercial said Mikulski. “This will lead to new products that have the powee to create jobs andsave lives.” Mikulski announced the firsf phase of the tech transfer program in March 2005 when 11 companies receive d funding. in Rockville: The company is developing a health care technolog y calledmiTag system, which is a scalabler wireless sensor solution for improving patient in Frederick: The company is developing a technology calleed the GeNova Screen to identify, and produce antibody-like molecules.
in The company is developing an on-demand biotech products includinf a combination vaccine against plaguesand anthrax. BioAssay Works LLC in The company is developinga lateral-flow visualp diagnostic test to detect and differentiatwe single sample multiple pathogenic poxviruses, includinhg variola, vaccinia, and monkeypox. in Catonsville: The company is safety-testinfg a medical product called which isa non-compressible, intracavitary hemostatic agent. CynerGened IDMP in Frederick: The companhy is developing, validating and implementing a supplemental diagnosisof HIV, and Dengue using its Infectious Diseasew Multiplex Panel approach, which could allow for creation of biosensors.
LLC in Baltimore: The companyg is developing required components and system frameworlk to enable conversational interfaces fortelemedicind tools. Such tools would allow professionap medics touse voice, gesture, and othefr human-- computer interactions to accesz and document information in electronid medical records. in Rockville: The company is developing technology to preserve mammalian cell in dried format that can easilybe re-hydratec for a variety of uses. LLC in The company is evaluatingf the effect of Imagilin patented probiotics as a food supplement to enhancwe the immune responsiveness of guinea pigs upon immunization or challengew withvirulent pathogens.
The evaluation will suggest the abilituy of Imagilin patented probiotics to enhance the immunization of a in Baltimore: The company is developing micropatternerd substrates for viral infectivity assays. Juxtopiw in Baltimore: The company is customizing its Wearable Assistance and SituationaoAwareness (WASA) goggles and service to allo w U.S. Army combat medics to acces s and document information to electrical medical recordsvia hands-free voice-requests and voice-responses. in Baltimore: The company is developinh cell therapies to treat brain and spinalcord injuries.